kTMP in Chronic Stroke

Part of paid clinical trials in San Francisco, California.

Sponsor
University of California, San Francisco
Study ID
NCT07277595
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Arm Weakness as a Consequence of Stroke
  • Chronic Stroke Patients
  • Stroke

Eligibility Criteria

Sex
ALL
Age
18 Years - 80 Years
Healthy Volunteers
Not accepted

Interventions

  • kTMP sham stimulation 9 weeks + active stimulation 9 weeks — DEVICE
    kTMP 9 weeks sham-kTMP stimulation, followed by 9 weeks active kTMP stimulation
  • kTMP 18 weeks — DEVICE
    Participants receive kTMP active stimulation for 18 weeks

Study Details

kTMP, kilohertz transcutaneous magnetic perturbations, is a low intensity transcranial magnetic stimulation technique that will be used in this study to promote arm/hand rehabilitation in patients who have been disabled by stroke.

Key Dates

Start date
Jul 1, 2026
Status verified
May 2026
Primary completion
Aug 1, 2030
Completion
Aug 1, 2030

Study Design

Enrollment
100 participants (estimated)
Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT

Arms

  • Active Comparator: Active Treatment
    Active treatment with kTMP for 18 weeks
  • Other: Crossover Treatment
    Initial 9 weeks will receive sham kTMP treatment, followed by 9 weeks of active kTMP treatment.

Primary Outcome Measure

Fugl Meyer Assessment [ Time Frame: Enrollment, then weeks 3, 6, 9, 12, 15, 18, and 34. ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of California, San FranciscoSan FranciscoCalifornia94158-

Find similar trials in San Francisco, CA

By condition

Related Studies